Latest filing published 30 Jan 2025 for Becton Dickinson & Co. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Catherine M. Burzik (board member) discloses dealings in 3 companies, chiefly Orthofix Medical Inc., Becton Dickinson & Co and Haemonetics Corp. The record holds 16 filings, for trades running from 26 January 2016 to 28 January 2025.
On the market, this insider has only ever bought: 1 purchase, €44k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 15 share grants.
Most recently, on 30 January 2025, the filings show a share grant in Becton Dickinson & Co. The clock since the last published purchase (19 November 2021) now reads 1,794 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations